Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Aier Eye Hospital is a prominent specialized medical institution and a flagship branch of the Aier Eye Hospital Group, one of the world's largest ophthalmology networks. Located in Wuhan, China, the hospital provides a full spectrum of ophthalmic services, including advanced refractive surgery, cataract treatment, glaucoma management, and pediatric eye care. It serves as a major center for clinical practice, medical education, and ophthalmic research within the Hubei province. The facility is equipped with state-of-the-art diagnostic and surgical technologies, such as femtosecond lasers and high-resolution imaging systems. As part of a publicly traded group, Wuhan Aier adheres to international standards of eye care and contributes significantly to the group's large-scale clinical data and research initiatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Aier Eye Hospital.